These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28250328)

  • 61. Drugs and non-medical products sold in pharmacy: information and advertising.
    Bernardini C; Ambrogi V; Perioli L
    Pharmacol Res; 2003 Jun; 47(6):501-8. PubMed ID: 12742003
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Actual state of medical activities as "home pharmacy" including preventive medicine in community pharmacy and their regional differences].
    Suzuki J; Ohtsu Y; Hashimoto M; Kaiho F
    Yakugaku Zasshi; 2008 Dec; 128(12):1819-31. PubMed ID: 19043302
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Driving under the influence…].
    Junod V; Baud CA; Broers B; Schmitt-Koopmann C; Bamert L; Simon O
    Rev Med Suisse; 2022 Jun; 18(787):1244-1247. PubMed ID: 35735147
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Guideline for evaluating the effects of psychotropic drugs on motor vehicle driving performance in Japan: A tiered approach for the assessment of clinically meaningful driving impairment.
    Nakabayashi T; Iwamoto K; Yamaguchi A; Konishi Y; Saji M; Yoshimura R; Kanemoto K; Aoki H; Ando M; Ozaki N
    Neuropsychopharmacol Rep; 2024 Jun; 44(2):308-313. PubMed ID: 38624143
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A study comparing the effectiveness of three warning labels on the package of driving-impairing medicines.
    Emich B; van Dijk L; Monteiro SP; de Gier JJ
    Int J Clin Pharm; 2014 Dec; 36(6):1152-9. PubMed ID: 25204257
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of a Japanese drug alert pictogram on medication-taking/driving behavior.
    Fukuda Y; Ando S; Saito M
    Traffic Inj Prev; 2020; 21(1):18-23. PubMed ID: 31770002
    [No Abstract]   [Full Text] [Related]  

  • 67. Psychoactive medication and traffic safety.
    Verster JC; Mets MA
    Int J Environ Res Public Health; 2009 Mar; 6(3):1041-54. PubMed ID: 19440432
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The new guideline for evaluating effects of psychotropic drugs on the performance to drive a motor vehicle in Japan: Comparison with US FDA guideline.
    Iwamoto K; Nakabayashi T; Yamaguchi A; Konishi Y; Saji M; Yoshimura R; Kanemoto K; Aoki H; Ando M; Ozaki N
    Neuropsychopharmacol Rep; 2023 Jun; 43(2):172-176. PubMed ID: 37057649
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evidence based information on drug use during pregnancy: a survey of community pharmacists in three countries.
    Lyszkiewicz DA; Gerichhausen S; Björnsdóttir I; Einarson TR; Koren G; Einarson A
    Pharm World Sci; 2001 Apr; 23(2):76-81. PubMed ID: 11411449
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Collection of medical drug information in pharmacies: Drug Event Monitoring (DEM) in Japan.
    Hayashi S; Nanaumi A; Akiba Y; Komiyama T; Takeuchi K
    Yakugaku Zasshi; 2005 Jul; 125(7):555-65. PubMed ID: 15997212
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Factors influencing changes in medication-taking and driving behavior after warnings about prescription medications that prohibit driving: an online survey.
    Fukuda Y; Saito M
    BMC Public Health; 2022 May; 22(1):1020. PubMed ID: 35596168
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Most dentists approve of oral health check-ups for local residents at community pharmacies and desire collaboration with community pharmacists.
    Iwata H; Nakamura K; Kobayashi N; Fujimoto K; Hayashi N; Yamaura K
    Drug Discov Ther; 2022 Dec; 16(6):309-312. PubMed ID: 36529485
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Community pharmacists' measurement of health-related quality of life in outpatients taking high-risk drugs.
    Ichimura T; Ogawa C; Murata H; Miyahara K; Yuge S; Tsukioka R; Kado K; Yoshimura T; Suzuki K; Nomura H; Shimizu H
    Pharmazie; 2022 Jun; 77(6):202-206. PubMed ID: 35751159
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prescription drugs and driving performance.
    Cowart V; Kandela P
    JAMA; 1985 Jul; 254(1):15, 20-2, 27. PubMed ID: 3999344
    [No Abstract]   [Full Text] [Related]  

  • 75. Measuring adherence in community pharmacies: opportunities and challenges.
    Svarstad BL
    J Am Pharm Assoc (2003); 2005; 45(2):127-9. PubMed ID: 15868753
    [No Abstract]   [Full Text] [Related]  

  • 76. The effectiveness of four education strategies in the elderly.
    Ascione FJ; Shimp LA
    Drug Intell Clin Pharm; 1984 Nov; 18(11):926-31. PubMed ID: 6499663
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Factors inhibiting community pharmacists' participation in homecare medicine in Ise city, Mie prefecture].
    Hayashi M; Ooi K
    Nihon Ronen Igakkai Zasshi; 2014; 51(5):466-9. PubMed ID: 25492677
    [No Abstract]   [Full Text] [Related]  

  • 78. Biotech pharmacy addresses patient compliance.
    Roth R; Constantine LM
    Am Pharm; 1995 Jul; NS35(7):19-21. PubMed ID: 7661101
    [No Abstract]   [Full Text] [Related]  

  • 79. Handling patients' calls about news reports on drug therapy.
    Fry RN; Greiner DL
    Am J Health Syst Pharm; 1996 Jul; 53(14):1662-4. PubMed ID: 8827231
    [No Abstract]   [Full Text] [Related]  

  • 80. Patient education materials provided by community pharmacies.
    Morris LA; Moore SR
    Am Pharm; 1983 Nov; NS23(11):21-4. PubMed ID: 6650383
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.